Archives for March 9, 2005

← 2005

Report finds CSOs paid the lowest

A recent report into salaries within the pharmaceutical industry reveals that the Chief Scientific Officer (CSO) is paid amongst the lowest for all executives when compared to salaries paid to chief executive officers (CEOs).

Microcapsules help cells grow in 3D

The Institute of Bioengineering and Nanotechnology (IBN) in Singapore has developed a method to cultivate cells cost-efficiently in a 3-dimensional configuration that mimics the cell environment in our body, paving the way improved cell culture...

Bespoke answer to tough packaging challenge

Schneider Electric has teamed up with automated handling company PES Technology to develop a bespoke packaging line for a hazardous and time-critical pharmaceuticals process.

Revolutionary technique "cures" diabetic

Drug therapies for sufferers of diabetes may become a thing of the past as UK doctors performed a groundbreaking cell transplant technique on a patient making him the first person to be "cured" of the illness.

Amino acids for synthesis to be $1bn market

Sales of amino acids used in synthesis applications will reach nearly $1 billion in 2009 and represent the fastest-growing category in the $7 billion amino acids market.

BioAlliance shows styrylquinoline synergy with HIV drugs

BioAlliance Pharma, a biopharmaceutical company focused on the field of drug resistance may have discovered a novel way to overcome growing HIV resistance. They have developed a new family of integrase binding inhibitors, which show synergy with...

Second study finds biopharma in overcapacity

A second market research report has found evidence that production capacity in the market for contract manufacturing of biopharmaceuticals is now in excess, in contrast to the hitherto prevailing wisdom that the sector has been suffering from...

Computational tool predicts drugs action in cells

Biomedical engineers and chemists have collaborated on a novel method that predicts how drugs work in cells. The tool will allow drug developers to design compounds that will act on a desired gene and protein targets, eliciting therapeutic responses...